{
    "2021-04-22": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Were Hedge Funds Right About AbbVie (ABBV)?",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Right",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "AbbVie Receives Health Canada Approval of HUMIRAÂ® (adalimumab) for the Treatment of Pediatric Patients with Moderately to Severely Active Ulcerative Colitis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Health Canada",
                        "Approval",
                        "HUMIRA",
                        "Pediatric",
                        "Ulcerative Colitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point?",
                "features": {
                    "keywords": [
                        "Buy",
                        "AbbVie",
                        "Stock",
                        "Buy Point"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}